Henrik Rasmussen Net Worth

The estimated Net Worth of Henrik S Md Rasmussen is at least $13.1 Million dollars as of 3 June 2021. Henrik Rasmussen owns over 2,435 units of Allakos Inc stock worth over $60,116 and over the last 6 years he sold ALLK stock worth over $7,457,887. In addition, he makes $5,596,090 as Chief Medical Officer at Allakos Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Henrik Rasmussen ALLK stock SEC Form 4 insiders trading

Henrik has made over 3 trades of the Allakos Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 2,435 units of ALLK stock worth $218,176 on 3 June 2021.

The largest trade he's ever made was selling 61,952 units of Allakos Inc stock on 1 March 2021 worth over $7,239,711. On average, Henrik trades about 19,065 units every 16 days since 2018. As of 3 June 2021 he still owns at least 98,550 units of Allakos Inc stock.

You can see the complete history of Henrik Rasmussen stock trades at the bottom of the page.

Henrik Rasmussen biography

Dr. Henrik Sandvad Rasmussen M.D. Ph.D serves as Chief Medical Officer of the Company. From October 2012 through June 2016, Dr. Rasmussen served as Chief Medical Officer at ZS Pharma, a biotechnology company. From August 2009 to October 2012 and from June 2015 to June 2017, Dr. Rasmussen served as President and Chief Executive Officer of Rasmussen Biotech and Pharma Consulting. Dr. Rasmussen also previously held the positions of Corporate Vice President and Head of Clinical Development and Medical and Regulatory Affairs at Novo Nordisk. He also previously served as Chief Medical Officer for Nabi Biopharmaceuticals and Genvec. He was also previously Vice President for Clinical Research and Senior Vice President for Clinical Research and Regulatory Affairs at British Biotech and International Clinical Project Manager and Global Study Director for cardiovascular drug development at Pfizer Central Research. Dr. Rasmussen has led numerous global development programs and regulatory filings worldwide, including NDAs. Dr. Rasmussen received his M.D. and Ph.D. from the University of Copenhagen in Denmark and is trained in internal medicine and cardiology.

What is the salary of Henrik Rasmussen?

As the Chief Medical Officer of Allakos Inc, the total compensation of Henrik Rasmussen at Allakos Inc is $5,596,090. There are 2 executives at Allakos Inc getting paid more, with Robert Alexander having the highest compensation of $12,559,300.

How old is Henrik Rasmussen?

Henrik Rasmussen is 60, he's been the Chief Medical Officer of Allakos Inc since 2017. There are 2 older and 8 younger executives at Allakos Inc. The oldest executive at Allakos Inc is Steven James, 62, who is the Independent Director.

What's Henrik Rasmussen's mailing address?

Henrik's mailing address filed with the SEC is 75 Shoreway Rd A, San Carlos, CA 94070, USA.

Insiders trading at Allakos Inc

Over the last 6 years, insiders at Allakos Inc have traded over $246,100,922 worth of Allakos Inc stock and bought 5,181,222 units worth $35,384,176 . The most active insiders traders include Paul Edward Walker, Group, Llc Green Jeremy Red..., and Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of $114,372. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth $87,935.

What does Allakos Inc do?

allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.

Complete history of Henrik Rasmussen stock trades at Allakos Inc

Allakos Inc executives and stock owners

Allakos Inc executives and other stock owners filed with the SEC include:

• Robert Alexander,
  Chief Executive Officer, Director
• Adam Tomasi,
  President, Chief Operating Officer
• Henrik Rasmussen,
  Chief Medical Officer
• Leo Redmond,
  Chief Financial Officer
• Mark Asbury,
  Chief Legal Officer and General Counsel
• Dr. Robert Alexander Ph.D.,
  CEO & Director
• Dr. Adam L. Tomasi Ph.D.,
  Pres & COO
• Dr. Henrik Sandvad Rasmussen,
  Strategic Advisor
• Mark Asbury,
  Chief Legal Officer & Gen. Counsel
• Daniel Janney,
  Independent Chair of the Board
• Robert Andreatta,
  Independent Director
• John McKearn,
  Independent Director
• Paul Walker,
  Independent Director
• Steven James,
  Independent Director
• Dr. Craig Paterson M.D.,
  Chief Medical Officer
• Alan Chang,
  Director of Medical Affairs & Data Analytics
• Tim Varacek,
  Chief Commercial Officer
• Dr. Sally D. Bolmer,
  Sr. VP of Regulatory Affairs & Drug Devel.
• Dr. Ruby Casareno Ph.D.,
  Sr. VP of Technical Operations
• Baird Radford III,
  Chief Financial Officer
• Group, Llc Green Jeremy Red...,
  
• Venture Fund Iii, L.P.River...,
  
• Partners Viii, L.P.Alta Par...,
  
• Neil Murray Hamilton Graham,
  
• Amy L Ladd,
  
• Dolca Thomas,
  
• Partners Next Gen Fund I Ma...,
  
• Peter A Hudson,
  
• Robert J More,
  
• Guy P Nohra,
  10% owner
• Natalie C. Holles,
  Director
• Partners Next Gen Fund I Ma...,
  
• Margaret Nell Fitzgerald,
  General Counsel and Secretary
• Craig A. Paterson,
  Chief Medical Officer
• Everett Rand Sutherland,
  Director
• Partners Management Viii, L...,
  
• Chin Hyok Lee,
  Chief Medical Officer
• Harlan Baird Radford,
  Chief Financial Officer